I just read this from the Associated Press. I didnt search to see if it has been discussed or mentioned on here yet so forgive me if it has:
An asthma inhaler already sold overseas received US approval. AstraZeneca PLC's Symbicort received approval for the longterm maintenance of asthma in patients 12 & older. Symbicort combines budesonide and formoterol fumarate dihydrate. It is inhaled as an aerosol. Budesonide is an inhaled corticosteroid and provides an anti-inflammatory affect, while formoterol is a rapid and long lasting bronchodilator. Symbicort is approved for sale in more tham 90 countries. It is expected to compete against the drug, Advair.
An asthma inhaler already sold overseas received US approval. AstraZeneca PLC's Symbicort received approval for the longterm maintenance of asthma in patients 12 & older. Symbicort combines budesonide and formoterol fumarate dihydrate. It is inhaled as an aerosol. Budesonide is an inhaled corticosteroid and provides an anti-inflammatory affect, while formoterol is a rapid and long lasting bronchodilator. Symbicort is approved for sale in more tham 90 countries. It is expected to compete against the drug, Advair.